Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to $63.5 million.

  • Prestige Consumer Healthcare's Accumulated Expenses rose 19.36% to $68.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.5 million, marking a year-over-year increase of 19.36%. This contributed to the annual value of $63.5 million for FY2025, which is 13.01% up from last year.
  • According to the latest figures from FY2025, Prestige Consumer Healthcare's Accumulated Expenses is $63.5 million, which was up 13.01% from $56.2 million recorded in FY2024.
  • Prestige Consumer Healthcare's Accumulated Expenses' 5-year high stood at $74.1 million during FY2022, with a 5-year trough of $56.2 million in FY2024.
  • Over the past 3 years, Prestige Consumer Healthcare's median Accumulated Expenses value was $63.5 million (recorded in 2025), while the average stood at $64.0 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Accumulated Expenses increased by 20.70% in 2022, and later declined by 22.57% in 2024.
  • Yearly analysis of 5 years shows Prestige Consumer Healthcare's Accumulated Expenses stood at $61.4 million in 2021, then grew by 20.70% to $74.1 million in 2022, then decreased by 2.14% to $72.5 million in 2023, then declined by 22.57% to $56.2 million in 2024, then rose by 13.01% to $63.5 million in 2025.